Clinical Microbiology Reviews

Papers
(The TQCC of Clinical Microbiology Reviews is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Extracutaneous sporotrichosis401
2025 Acknowledgment of CMR Reviewers191
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders180
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility140
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections138
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease137
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”129
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance119
Integrating whole-genome sequencing into antimicrobial resistance surveillance: methodologies, challenges, and perspectives119
Viral infections and pathogenesis of glaucoma: a comprehensive review104
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities97
The sex hormone-gut microbiome axis: mechanistic drivers of sex-disparate bacterial infection outcomes and precision clinical interventions94
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves92
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant91
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus89
Progression of antibiotic resistance in Neisseria meningitidis85
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options84
Decontamination approaches and strategies for the prevention of sink drain-related healthcare-associated infections81
A review of post-exposure strategies for high-consequence viral pathogens in the laboratory81
Canonical fact versus hypothesis testing to decipher transmission of non-tuberculous and tuberculous mycobacteria: a comparative review76
Review of BCG immunotherapy for bladder cancer74
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics71
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance69
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms69
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control69
Neisseria gonorrhoeae vaccines: a contemporary overview62
Congenital Syphilis: a Review of Global Epidemiology62
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen62
Erratum for Cho et al., “Recent advances in therapeutic probiotics: insights from human trials”59
Bacterial and fungal infections in persons who inject drugs57
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature57
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease56
BCG therapy in bladder cancer and its tumor microenvironment interactions53
Diagnosis, Management, and Future Control of Cholera52
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes52
Rapid and accurate testing for urinary tract infection: new clothes for the emperor52
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections51
Agnostic Sequencing for Detection of Viral Pathogens50
Artemisinin-resistant malaria50
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)49
Convalescent plasma for COVID-19: planning for the next pandemic using the worldwide experience49
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome43
Editorial Board42
2021 Acknowledgment of CMR Reviewers42
Harnessing the host response for precision infectious disease diagnosis42
Floods and infectious diseases: public health lessons from the 2024 southern Brazil disaster40
COVID-19 therapeutics38
0.027547121047974